NCT03604133 (ASC ICD Reg) is a clinical trial in Arrhythmia, sponsored by QuesGen Systems Inc.

Who is sponsoring NCT03604133?

NCT03604133 is sponsored by QuesGen Systems Inc.

What condition does NCT03604133 study?

NCT03604133 studies Arrhythmia.

Is NCT03604133 still recruiting?

NCT03604133 is currently recruiting now. Last updated 22 January 2021.

Last reviewed 2021-01-22 · How we verify

NCT03604133: ASC ICD Reg

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ambulatory Surgical Center Implantable Cardioverter-Defibrillator Outcomes Registry

Recruiting now Last updated 22 January 2021

What this trial tests

trial in Arrhythmia in 500 participants. Currently enrolling.

Timeline

24 August 2017

Primary endpoint
24 August 2023

24 August 2028

Quick facts

Lead sponsor	QuesGen Systems Inc
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	24 August 2017
Primary completion	24 August 2023
Estimated completion	24 August 2028
Sites	1 location across United States

Conditions studied

Arrhythmia — all drugs for Arrhythmia →

Sponsor

QuesGen Systems Inc

Who can join

Eligibility, any sex, with Arrhythmia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arrhythmia

Currently open trials in the same condition.

NCT06989580 — BIO|CONCEPT.BIOMONITOR-HF Collect Clinical Data From Heart Failure Patients Using BIOMONITOR Devices With a Study Specif · NA · recruiting
NCT07096973 — Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery · recruiting
NCT06808204 — Quality of Life Before and After Transcatheter Ablation in Children With Arrythmias · NA · recruiting
NCT06984731 — The Safety and Efficacy of Radiofrequency Ablation After Left Atrial Appendage Occlusion. · recruiting
NCT06954103 — Mechanisms And Prognosis of Stroke-Heart Syndrome · recruiting

Other QuesGen Systems Inc trials

Trials by the same sponsor.

NCT03883633 — Reversal of Cognitive Decline (ReCODE) Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03604133 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by QuesGen Systems Inc
Last refreshed: 22 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03604133.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing